ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AZN Astrazeneca Plc

11,850.00
-86.00 (-0.72%)
15 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -86.00 -0.72% 11,850.00 11,876.00 11,878.00 12,056.00 11,814.00 12,006.00 1,719,597 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8412 30.92 185.04B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 11,936p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 13,338.00p.

Astrazeneca currently has 1,550,294,658 shares in issue. The market capitalisation of Astrazeneca is £185.04 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 30.92.

Astrazeneca Share Discussion Threads

Showing 4751 to 4772 of 6200 messages
Chat Pages: Latest  200  199  198  197  196  195  194  193  192  191  190  189  Older
DateSubjectAuthorDiscuss
13/4/2021
15:36
Seems J&J and Astra used the same vaccine technology.Interesting article.
montyhedge
13/4/2021
15:34
https://www.theguardian.com/world/2021/apr/13/johnson-johnson-covid-vaccine-blood-clots
montyhedge
13/4/2021
14:31
Official figures show exports to the EU jumped by 46.6%, £3.7bn, to £11.6bn, following January's 42% slump when firms struggled with new trade rules.
coxsmn
13/4/2021
14:30
Tempted to buy back some, thinking sub £70 - which may not be available.
essentialinvestor
13/4/2021
12:58
Guess that is the idea, but have no magic wand.
dudishes
13/4/2021
12:58
The share count increase in more than exceeded by EPS accretion in FY 1
post acquisition closure.

Analysts are currently modelling at an approx 9% annualised EPS accretion
net.

essentialinvestor
13/4/2021
12:57
US regulators have called for the rollout of Johnson & Johnson’s single-dose jab to be paused after six vaccinated women developed blood clots
clinton baptiste
13/4/2021
12:54
Wrong- more shares outstanding but an even bigger increase in profits from including Alexion so earnings per share will be higher
smcni1968
13/4/2021
10:20
When the Alexion finally completes second half of this year, I'm I right 15% dilution in Astra shares, has part of the deal. Is that right or wrong ?
montyhedge
13/4/2021
09:30
Should go up as b3 appears on board.LOL.
action
12/4/2021
07:46
It really did make you wonder when you saw the recent England cricket matches taking place in stadiums with a crowd rammed in - what were they thinking?
imastu pidgitaswell
12/4/2021
05:58
India is now in a terrible state with Covid cases rising exponentially 150k plus a day

100M have been vaccinated

They need more than 1 Billion doses just to try to look after their own

Another 1 Billion for the second dose
The Serum Institute of India ( world biggest vaccine maker) , is trying to fill orders from all over , but will politicians in India now put India first ?

It has been reported that there are now 800 variants of concern in India and since it took circa 80 days to reach 100M --- and with current vaccine shortages in many states --- India looks set to take over the world number one spot from the USA within the next couple of months.

India now has all three coronavirus fast-spreading variants that are worrying the global medical community -- B117, first detected in the UK; B1351, now dominant in South Africa; and Brazil’s P1. And now a “double-mutant” variant found in India. Because of a severe lack of genome-sequencing labs, we have little idea of how fast and to what extent these variants are spreading across the country.

Meantime Australia is halting their vaccine roll-out in the light of AZN developments and seem to be going the Pfizer route .

One wonders if the SA variant might get established whilst they get sorted

The UK does seem to be out in front for now , what the next couple of months holds with easing of restrictions and schools open remains to be seen . Especially if International travelers start arriving in numbers

buywell3
11/4/2021
19:02
Worth reading behind the headlines.



6. We think that this reduced effectiveness occurs only in a short window of time (no B.1.351 cases 14+ days post 2nd dose), and that the S.A. variant does not spread efficiently. Thus, even more of a reason to get vaccinated and drive down cases to zero!

blusteradjuster
11/4/2021
19:01
COVID-19: Former AstraZeneca board member defends firm over its handling of vaccine rollout


Professor Dame Nancy Rothwell said she expects those inside the company are feeling they have "had a bit of a hard time".

philanderer
10/4/2021
09:34
Apparently, the N501Y mutation, seen in all variants of concern, is a main driver of stronger binding between Coronavirus spike and the ACE-2 receptor on our cells.

If that stronger-binding increases the chance of entry to the cell (and its ribosomes - the production-line for viral replication) then naturally, replication will be improved.

So, there will be more virus to overwhelm our defences (increased lethality), more virus escaping us (entropy - the more inside there is, the more there is to escape into the air around us). More virus coming out of us means more to infect others (increased transmission) and finally that stronger-binding means a lower average threshold (amount of virus getting into next ‘victim’) needed to seed a new infection (again, increased transmission).

It’s all a numbers game ... but have we seen the best the virus can give?

blusteradjuster
10/4/2021
09:15
Prior infection strongly protects against the British variant at least.

Do the Brazil & South African reduce naturally/vaccine acquired protection?

Possibly but increased transmissibility is likely the main component of increased spread.

Think of England (particularly London/SE) late 2020: Rt went above 1 even in lockdown late-November and went further above 1 .. until Jan 5th.

That wasn’t vaccine-escape (no vaccines) or reinfection from B.1.1.7 (see link below).

It was just the simple fact that:

Rt < 1 —> better days
Rt > 1 —> worse days

blusteradjuster
09/4/2021
17:50
Still no herd immunity in Manaus Brazil, eventhough it was suggested that
milestone had been reached late last year - so either wanning immunity, reinfections
with a new variant (P1) or an overestimating of the numbers who would be immune
by late 2020 - perhaps an element of all 3.

Israel data looks very positive as does the UK, vaccination clearly working.
The key is can we prevent mass new variant reinfections and if people get
reinfected could previous infection/existing vaccines mitigate more serious cases.

Even If millions get reinfected, but with mild or asymptomatic cases, then
we can still pretty much return to normal.


BMJ article on Brazil:

essentialinvestor
09/4/2021
16:55
It'll take forever to reach herd immunity that way, EI.

Why they don't they go door to door..?

blusteradjuster
09/4/2021
16:02
* Human trials at the Royal Free in Hampstead where healthy volunteers are
intentionally infected with the virus.

It was cleared by the ethics committee back in February so may now be underway.

essentialinvestor
09/4/2021
15:53
Don't know why the EMA don't just approve a blast of SARS-CoV-2 up the nose and be done with it.
blusteradjuster
09/4/2021
15:38
Have the Americans been hiding their data?
raydxx
09/4/2021
15:34
J&J uses the same delivery mechanism as the AZN vaccine I read somewhere. I also read there are Pfizer cases too. Lots of noise. Lots of lobbying going on.
minerve 2
Chat Pages: Latest  200  199  198  197  196  195  194  193  192  191  190  189  Older

Your Recent History

Delayed Upgrade Clock